Scroll to Top
Open Letter from the Pharmaceutical Industry Heads of Research and EFPIA on the Relocation of the European Medicines Agency
24 April 2017
Our current system of medicines regulation offers an outstanding example of European cooperation at its finest. By joining forces across nation states, bringing together the ...
Open Invitation for ATMP-developers to help improve product development and its regulation
31 March 2017
Advanced Therapy Medicinal Products (ATMPs) are medicinal products including gene therapies, somatic cell therapies and tissue engineered products. They are characterised by their innovative character, ...
New project: success and failure in the development and commercialisation of ATMP products
01 March 2017
With recent developments in innovative technologies, new opportunities arise to address the demands of an ageing population, as well as diseases with high unmet medical ...
Joint Declaration on EU Industrial Strategy
20 February 2017
Europe is the cradle of the manufacturing industry and has been at the forefront of industrial revolutions and technological innovations. The industry directly employs over 34 ...
EFPIA statement on the ENVI Committee’s Report on Access to Medicines
01 February 2017
EFPIA notes yesterday’s adoption of the INI report by the European Parliament's Committee on Environment, Public Health and Food Safety (ENVI) on EU options for improving access to ...
The Value of the Pharmaceutical Industry; key to Europe’s economy
16 January 2017
The pharmaceutical industry continues to be a key driver of growth in the European economy. This is just one of the principle conclusions drawn by ...
Statement from EFPIA President Joe Jimenez on the upcoming OECD Health Ministerial
16 January 2017
On January 17, Health Ministers from OECD countries will gather in Paris, France, to discuss how healthcare systems can reform to better deal with the ...
Eric Cornut appointed Interim Director General as Richard Bergström leaves EFPIA
12 December 2016
Today, EFPIA announces the appointment of Eric Cornut as Interim Director General, succeeding Richard Bergström after five successful years at the head of the association. From ...
EFPIA Health Collaboration 2016 Summary Report
17 November 2016
Andrzej Rys, Health Systems and Medical products and Innovation Director at the European Commission, opened the EFPIA Health Collaboration Summit 2016, from 9-10 November, by ...
Health Collaboration Summit 2016 - a summary of the first day
10 November 2016
The primary session of the EFPIA Health Collaboration Summit 2016 focused on tools that might be introduced to overcome the significant challenges faced by European ...
Page 1 of 16
Press Releases & Statements
Enabling Technologies for Better Patient Outcomes - Live Streaming
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman